HealthInvest Partners AB »

Oruka Therapeutics shares owned by HealthInvest Partners AB

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by HealthInvest Partners AB from 13F filings

Historical chart of HealthInvest Partners AB investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by HealthInvest Partners AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 55k 95.17

More positions owned by HealthInvest Partners AB

Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
CVS Caremark Corporation (CVS)
Thermo Fisher Scientific (TMO)
Revolution Medicines (RVMD)
Biogen Idec (BIIB)
Neurocrine Biosciences (NBIX)
Mirum Pharmaceuticals (MIRM)
Alkermes SHS (ALKS)
Ionis Pharmaceuticals (IONS)
Beone Medicines Ltd- Sponsored Ads (ONC)
Intuitive Surgical Com New (ISRG)
Stryker Corporation (SYK)

View all positions for HealthInvest Partners AB

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
Vanguard Capital Management
State Street Corporation
Remedium Capital Partners
Perceptive Advisors
Polar Capital Holdings
Citadel Advisors
Franklin Resources

View all funds holding Oruka Therapeutics